Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1)

[Edit]

FEZ1; F37/Esophageal Cancer-Related Gene-Coding Leucine-Zipper Motif

Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1)
LZTS1 encodes a tumor suppressor protein that is ubiquitously expressed in normal tissues. In uveal melanomas, expression of this protein is silenced in rapidly metastasizing and metastatic tumor cells but has normal expression in slowly metastasizing or nonmetastasizing tumor cells. This protein may have a role in cell-cycle control by interacting with the Cdk1/cyclinB1 complex. This gene is located on chromosomal region 8p22. Loss of heterozygosity (LOH) in the 8p arm is a common characteristic of many types of cancer. FEZ1 expression was undetectable in more than 60% of epithelial tumors, but FEZ1 mutations were found in primary esophageal cancers and in a prostate cancer cell line. Transcript analysis from several FEZ1-expressing tumors revealed truncated mRNAs, including a frameshift.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) ELISA Kit Customized Service Offer
  1. "The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors."Proc. Natl. Acad. Sci. U.S.A. 96:3928-3933(1999) [PubMed] [Europe PMC] [Abstract]
  2. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  3. "Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22."Oncogene 20:4169-4179(2001) [PubMed] [Europe PMC] [Abstract]
  4. "FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis."Proc. Natl. Acad. Sci. U.S.A. 98:10374-10379(2001) [PubMed] [Europe PMC] [Abstract]
  5. "FEZ1 dimerization and interaction with transcription regulatory proteins involves its coiled-coil region."J. Biol. Chem. 281:9869-9881(2006) [PubMed] [Europe PMC] [Abstract]
  6. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]